Apollon Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.4M Buy
67,842
+1,650
+2% +$1.69M 0.99% 15
2026
Q1
$60.9M Buy
66,192
+22,815
+53% +$23.1M 0.99% 14
2025
Q4
$46.6M Buy
43,377
+691
+2% +$661K 0.81% 23
2025
Q3
$32.6M Buy
42,686
+4,298
+11% +$3.2M 0.58% 34
2025
Q2
$29.9M Buy
38,388
+4,271
+13% +$3.32M 0.59% 33
2025
Q1
$28.2M Buy
34,117
+14,466
+74% +$12M 0.62% 33
2024
Q4
$15.2M Buy
19,651
+5,421
+38% +$4.49M 0.35% 58
2024
Q3
$12.6M Buy
14,230
+936
+7% +$842K 0.36% 57
2024
Q2
$12M Buy
13,294
+369
+3% +$295K 0.37% 53
2024
Q1
$10.1M Sell
12,925
-754
-6% -$537K 0.32% 59
2023
Q4
$7.97M Buy
13,679
+4,609
+51% +$2.69M 0.28% 70
2023
Q3
$4.87M Sell
9,070
-1,694
-16% -$873K 0.24% 78
2023
Q2
$5.05M Buy
10,764
+2,623
+32% +$1.1M 0.24% 85
2023
Q1
$2.8M Buy
8,141
+762
+10% +$257K 0.17% 123
2022
Q4
$2.7M Buy
7,379
+107
+1% +$37.9K 0.19% 115
2022
Q3
$2.35M Buy
7,272
+541
+8% +$171K 0.19% 120
2022
Q2
$2.18M Buy
6,731
+441
+7% +$132K 0.18% 118
2022
Q1
$1.8M Buy
6,290
+1,444
+30% +$372K 0.13% 174
2021
Q4
$1.34M Buy
4,846
+2,350
+94% +$596K 0.1% 226
2021
Q3
$577K Buy
2,496
+1,410
+130% +$348K 0.08% 245
2021
Q2
$249K Sell
1,086
-864
-44% -$174K 0.04% 316
2021
Q1
$364K Buy
+1,950
New +$381K 0.07% 241
2020
Q3
Sell
-213
Closed -$35K 456
2020
Q2
$35K Buy
+213
New +$32.7K 0.02% 294

Other funds holding LLY

Apollon Wealth Management's LLY Position: Q2 2026 in Review

Apollon Wealth Management increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $1.69M and bringing the position to 67,842 shares worth $81.4M. The position accounts for 0.99% of the portfolio, ranked #15.

Apollon Wealth Management first reported a position in LLY in Q2 2020 and has held it in 23 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Apollon Wealth Management held 67,842 shares of Eli Lilly worth $81.4M as of Q2 2026.
  • Apollon Wealth Management bought 1,650 Eli Lilly shares in Q2 2026, an estimated $1.69M.
  • Eli Lilly made up 0.99% of Apollon Wealth Management's portfolio in Q2 2026, its #15 holding.
  • Apollon Wealth Management first reported a position in Eli Lilly in Q2 2020 and has held it in 23 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.